From mid-September, Colines will make a Polycast 9-layer cast film extrusion test line available at its headquarters in Nibbia near Novara, Italy. The installation, which will also be offered for purchase with short delivery times, has been configured in a full-optional version and has a net width of 2500 mm. According to the manufacturer, the solution was designed for high application flexibility so as to enable the production of CPP, CPE and barrier films, both in symmetric and asymmetric structures. The line is intended for customer trials, testing of new film structures and discussion of future production projects.
As the company states, the installation can also be equipped with the Mastermind system, an artificial intelligence-based virtual production assistant. This solution is intended to allow users to assess the benefits of applying AI tools in the cast film extrusion process, including improved process stability, shorter start-ups and increased production consistency. The manufacturer also points to the package of technologies used, including continuous gravimetric dosing units from Doteco, a variable-geometry feedblock and the latest-generation Cloeren Reflex die. This configuration is intended to ensure high process flexibility and the quality of the produced film.
Line configuration and equipment scope
In its description of the installation, Colines also highlights the advanced thermoregulation system and the three-chill-roll configuration, specifically designed to optimize the annealing process. According to the company, this solution is intended to reduce post-winding shrinkage while at the same time enabling reels to be obtained that are ready directly for further converting. Additional equipment includes dual-side corona treatment, two separate edge-trim refeeding hoppers to maintain uninterrupted production, the Flexiwind II automatic winder with a multiple-cut system, and high flexibility in terms of net width.
The company invites interested customers to make contact in order to obtain further information and schedule trials at the Nibbia facility from mid-September onward.
